Our findings confirm that longer diabetes duration is associated with a lower glycaemic response to GLP-1 RAs [3, 6, 16], probably due to declining beta cell function, as intact insulin secretion is necessary for a robust glycaemic response to this drug class [1, 3]
We found similar alterations in the probability of cellcell communication events between C35 GABA4 and C35 Glut10 sender neurons and hypothalamic receiver neurons after treatment with acyl-GLP-1 or the GIPR antagonist compared with vehicle DIO controls, which clearly diverge from that of acyl-GIP (Fig
It will not promote weight loss
Retatrutide acts primarily through GLP 1, GIP, and glucagon receptor pathways
Topical Administration (Most Common) The most widely used approach is topical application via DMSO (dimethyl sulfoxide): Dissolve 3-5mg Dihexa in a few drops of DMSO Apply to forearm skin (DMSO acts as a carrier to drive the peptide through the skin) DMSO concentration: ~20-30% in the solution Pros: Effective absorption, avoids injection Cons: DMSO has a strong garlic-like odor that can transfer to breath/skin Starting Dose Begin at 1-3mg topically to assess response Work up to 3-5mg if tolerating well Cycling Protocol Dihexa appears to have lasting effects that persist after stopping likely due to synaptogenesis (new connections don't disappear when you stop)
